QGM
VYNT

Quality Growth Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Quality Growth Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$664K Buy
1,558
+201
+15% +$75.2K 0.75% 15
2015
Q4 		$672K Buy
+1,357
New +$980K 0.74% 14
2015
Q2 		$147K Sell
83
-74
-47% -$115K 0.15% 26
2015
Q1 		$184K Hold
157
– – 0.15% 22
2014
Q4 		$157K Buy
+157
New +$157K 0.12% 27

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Quality Growth Management's VYNT Position: Q1 2016 in Review

Quality Growth Management increased its Vyant Bio, Inc. Common Stock (VYNT) stake by 15% in Q1 2016, buying an estimated $75.2K and bringing the position to 1,558 shares worth $664K. The position accounts for 0.75% of the portfolio, ranked #15.

Quality Growth Management first reported a position in VYNT in Q4 2014 and has held it in 5 quarters since. The position peaked at $672K in Q4 2015. 29 funds tracked by Wall St. Rank hold VYNT as of Q1 2016.

  • Quality Growth Management held 1,558 shares of Vyant Bio, Inc. Common Stock worth $664K as of Q1 2016.
  • Quality Growth Management bought 201 Vyant Bio, Inc. Common Stock shares in Q1 2016, an estimated $75.2K.
  • Vyant Bio, Inc. Common Stock made up 0.75% of Quality Growth Management's portfolio in Q1 2016, its #15 holding.
  • Quality Growth Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2014 and has held it in 5 quarters since.
  • Quality Growth Management's Vyant Bio, Inc. Common Stock position peaked at $672K in Q4 2015.
  • 29 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2016.

Based on Quality Growth Management's 13F filing for Q1 2016, filed 15 Apr 2016.